跳至主要内容
临床试验/JPRN-jRCTs032180221
JPRN-jRCTs032180221暂停未知

Efficacy and Safety of Granulocytapheresis against severe alcoholic hepatitis - Efficacy and Safety of Granulocytapheresis against severe alcoholic hepatitis

akamoto Nobuhiro0 个研究点目标入组 30 人开始时间: 2019年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
暂停
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 70age old(—)
性别
All

入选标准

  • the patients who meet the diagnostic criteria of severe alcoholic hepatitis
  • the patients who are able to keep vascular access
  • the patients who obtained their written informed consent

排除标准

  • the patients whose granulocyte count are below 2000
  • the patients who complicated with severe infection, severe heart disease, uncontrolled cancer, and end-stage liver cirrhosis
  • the patients who are pregnant

研究者

发起方
akamoto Nobuhiro

相似试验